United Kingdom · Series A startup
One round we have observed, with the 7 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$11Mraised across 1 round since 2025, from 1 source
Missing a round, or an investor who was in one? Tell us.
Oxford Cancer Analytics (OXcan)'s investors include We Venture Capital, Cross-Border Impact Ventures, DigitalDx Ventures, Eka Ventures and Macmillan Cancer Support, and 2 more on record. We Venture Capital led its latest round.
Oxford Cancer Analytics (OXcan) has raised $11M across 1 round since 2025.
Oxford Cancer Analytics (OXcan)'s most recent round was a Series A of $11M in Jan 2025, led by We Venture Capital.
Its most recent round, $11M in Jan 2025, is also its largest on record.
Oxford Cancer Analytics (OXcan)'s first round on record, in Jan 2025, was backed by We Venture Capital, Cross-Border Impact Ventures and DigitalDx Ventures and 4 others.
Oxford Cancer Analytics (OXcan)'s latest named round is a Series A, in Jan 2025.
Oxford Cancer Analytics (OXcan) is based in the United Kingdom.
We Venture Capital led the Series A in 2025.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
